Job Trends
Labor Market Reports
BioSpace’s 2026 U.S. Life Sciences Employment Outlook examines the state of the biopharma workforce amid ongoing funding pressure, elevated layoffs and cautious hiring sentiment, while highlighting early signals of stabilization and cautious optimism for the year ahead.
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
Now Hiring
Last month, biopharmas let go or projected they would let go of less than 500 people combined, based on BioSpace estimates, down almost 1,000 from January 2025. Still, competition for open jobs remains strong, with employed and unemployed biotech and pharma professionals eyeing their next roles.
Looking for a biopharma job in Boston? Check out the BioSpace list of nine companies hiring life sciences professionals like you.
Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.
Career Advice
While you should never rely solely on AI tools when applying for jobs, they can greatly benefit the application process. Recruiting expert Bryan Blair discusses how using large language models can set you apart from the competition and includes a prompt framework to get you started.
THE LATEST
Biotech and pharma companies tap new members of executive leadership teams and boards.
The award provides priority admission or a one-year renewal for lab bench space and access to core facilities at the MBC BioLabs life sciences incubator.
This would appear to be a major step in understanding why and how checkpoint inhibitors work—or don’t work—and will potentially lead to another avenue of research and cancer treatment.
Biotech and pharma companies strengthen their leadership teams and committees with new appointments.
Chief Operating Officer Dan Paterson has been appointed to the role of president and will lead the company while the board of directors conducts a search for a new CEO.
A University of Houston researcher is examining the reaction in the brain at the precise moment when certain memories are seared into our minds.
Amgen hopes the data will provide insights into specific diseases that will help develop new drugs.
Neos Therapeutics, Inc. announced that Jerry McLaughlin, its Chief Executive Officer, will present a company overview at two upcoming conferences in June.
MD Anderson discovery provides new druggable targets to test against lethal brain tumor
The bankruptcy announcement comes weeks after Insys founder John Kapoor and four former executives were found guilty of orchestrating a kickback scheme to boost sales of its powerful opioid Subsys.